Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hepatol Res. 2015 Aug;45(8):856-62. doi: 10.1111/hepr.12425. Epub 2015 Jan 14.
The impact of intermittent inflow occlusion (Pringle maneuver) in living donor hepatectomy on the outcome of both the donor and the recipient is unknown. The aim of this study is to elucidate the safety and efficacy of Pringle maneuver in living donor hepatectomy.
Twenty consecutive cases of living donors who underwent left hepatectomy were prospectively divided into two groups, with (Group A, n = 10) or without (Group B, n = 10) the Pringle maneuver during hepatectomy. Intraoperative blood loss, postoperative liver functions in the donors and recipient outcome were reviewed.
Median blood loss was significantly less in group A than in group B. Median alanine aminotransferase was significantly higher on postoperative day 1 in group A than in group B, but the difference was not significant at 7 days after surgery. Eight of 10 recipients in each group survived with good graft function with a median follow-up period of 20 months in group A and 19 months in group B.
The Pringle maneuver was safely applied in living donor hepatectomy, but the only benefit was the reduction of blood loss during the donor surgery, and no positive impact on the recipient outcome.
间歇性入肝血流阻断(普雷令手法)对活体肝移植供体和受体的结局的影响尚不清楚。本研究旨在阐明普雷令手法在活体肝移植供体肝切除术中的安全性和有效性。
连续 20 例接受左半肝切除术的活体供肝者前瞻性地分为两组,肝切除术中应用(A 组,n=10)或不应用(B 组,n=10)普雷令手法。回顾分析术中出血量、供体和受体术后肝功能以及术后结果。
A 组的中位出血量明显少于 B 组。A 组术后第 1 天丙氨酸氨基转移酶中位数明显高于 B 组,但术后 7 天差异无统计学意义。两组各有 10 例受体存活,移植物功能良好,A 组中位随访时间为 20 个月,B 组为 19 个月。
普雷令手法可安全应用于活体肝移植供体肝切除,但仅能减少供体手术中的出血量,对受体结局无积极影响。